Innovation Sprint

Innovation Sprint, through its Healthentia product, develops an EU-certified Software as a Medical Device (SaMD) for patients, healthcare providers, clinics, hospitals, and researchers. Healthentia supports remote patient monitoring, real-world data collection, personalized virtual coaching, and digital therapeutics, with additional capabilities for decentralized clinical trials, observational studies, eConsent, eRecruitment, and study management. The platform is positioned as a trusted digital ecosystem for chronic disease management and clinical research, with an emphasis on certified, compliant, and clinically validated data. Its therapeutic focus includes chronic diseases such as cardiovascular disease, COPD, type 2 diabetes, and oncology. The company highlights a multidisciplinary team with more than 20 years of experience across life sciences, ICT solutions, and data analytics, including expertise in eHealth, Health Technology Assessment, machine learning, IoT devices, cybersecurity, and regulatory compliance. Innovation Sprint’s mission is to provide services to the life sciences sector, clinical research, and citizens while enabling better health outcomes through safer, smarter, and personalized digital care.